Manchester management co buys $1.29m in modular medical stock

Published 25/03/2025, 02:36
Manchester management co buys $1.29m in modular medical stock

In recent transactions involving Modular Medical (TASE:BLWV), Inc. (NASDAQ:MODD), a small-cap medical device company valued at $44.7 million, Manchester Management Co LLC, along with its affiliates, acquired a significant amount of common stock. According to InvestingPro data, the stock has shown strong momentum with a 25% gain over the past week, despite a challenging six-month period. The transactions, filed in a Form 4 with the Securities and Exchange Commission, reveal that Manchester Management Co purchased a total of 677,082 shares at a price of $1.92 per share. This acquisition represents a total investment of approximately $1.29 million. The company maintains a solid financial position with more cash than debt on its balance sheet and a healthy current ratio of 5.3x.

The shares were acquired in two separate transactions on March 20, 2025. Manchester Explorer, L.P., a related entity, purchased 520,832 shares, while James E. Besser, in his personal capacity, acquired 156,250 shares. Following these transactions, Manchester Management Co and its affiliates hold a substantial position in Modular Medical, with a total of 3,805,575 shares owned indirectly.

These transactions reflect Manchester Management Co’s continued interest in Modular Medical, further solidifying its position as a significant stakeholder in the company. For comprehensive insider trading analysis and additional financial insights, including 8 more exclusive ProTips, visit InvestingPro.

In other recent news, Modular Medical, Inc. has secured approximately $12 million in a private placement with institutional and accredited investors. This fundraising is aimed at enhancing the supply chain and improving margins for the MODD1 product, as well as developing a tubeless version for FDA submission later in 2025. Concurrently, the company is conducting a direct private placement to potentially raise an additional $500,000. At the company’s recent annual shareholder meeting, all seven director nominees were elected, and an amendment to the 2017 Equity Incentive Plan was approved, increasing the share reserve by 3,000,000 shares. The amendment to the equity plan is intended to help attract and retain talent. Additionally, the appointment of Farber Hass Hurley LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2025, was ratified. These developments highlight Modular Medical’s strategic moves to strengthen its operations and governance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.